The enteric nervous system consists of more than a dozen types of neurons aggregated into networks of ganglia throughout the gastrointestinal tract, which regulate contractile activity, mucosal secretion, absorption, and local blood flow. 1, 2 Mechanisms that contribute to remodeling of the enteric neuronal networks are of great interest. In the central nervous system, it has been suggested that microglia contribute to the fate, connectivity, and identity of neurons during development. 3 Muscularis propria macrophages (MPM) within the enteric nervous system may have similar functions to microglia. Mice homozygous for the osteopetrosis mutation (Csf1 op/op ) which do not have MPM, have more neurons in the small intestine 4 and a higher proportion of gastric neurons that express nitric oxide synthase (NOS1). 5 Myenteric neurons serve diverse functions that can be indicated by their morphology, projections and the expression of marker proteins that define their "chemical code." This study finds a previously unidentified Figure 1B and C, Supplementary Movie 1 and 2), were associated closely with neurons, suggesting functional interactions. 6 We first tested whether the number of choline acetyltransferase þ (ChAT Figure 2B) , indicating partial overlap between these markers. Therefore, we investigated whether the number of NOS1 Figure 2A and B) (Csf1 op/op : 7.8 ± 7.1 cells/field; WT, 1.7 ± 1.6 cells/field; 1-way analysis of variance; P < .001; n ¼ 24; N ¼ 4). This result suggests the ability of macrophages to not only modulate the neuronal number but also affect myenteric neuron differentiation. Enteric neurons are not required for bowel colonization by macrophages, 7 but macrophages interact with neurons after birth, by expressing genes, such as bone morphogenetic protein 2 (BMP2), needed for macrophageenteric neuron interaction and neuronal development. 4 To test the intrinsic ability of resident macrophages to modify the neuronal chemical code by establishing functional interaction with neurons, we treated Csf1 op/op with CSF1 (Colony Stimulating Factor 1) for 7 weeks to populate the stomach with macrophages ( Figure 2C ). In CSF1-treated Csf1 We previously showed that repopulating macrophages in CSF1-treated Csf1 op/op mice had a different phenotype from resident macrophages. 5 Consistent with this observation, BMP2 was not expressed by macrophages isolated from CSF1-treated Csf1 op/op mice (Antibodies and PCR primers listed in Supplementary  Tables 2 and 3) , whereas BMP2 was expressed by macrophages isolated from WT mice ( Figure 2D and E) (Mann-Whitney test; P < .001; N ¼ 4), as reported elsewhere. 4 During development, the chemical code of myenteric neurons changes and the overlap between NOS1 and ChAT decreases as neurons mature. Author contributions G. Cipriani was responsible for the study concept and design, acquisition, analysis, and interpretation of data, drafting of the manuscript, critical revision of the manuscript for important intellectual content, and statistical analysis; M. L. Terhaar was responsible for the analysis and interpretation of the data; S. T. Eisenman was responsible for the analysis and interpretation of the data; D. R. Linden was responsible for critical revision of the manuscript for important intellectual content; A.M. Wright was responsible for the acquisition, analysis, and interpretation of the data; S. Ji was responsible for the acquisition, analysis, and interpretation of data; L. Sha was responsible for critical revision of the manuscript for important intellectual content; T. Ordog was responsible for critical revision of the manuscript for important intellectual content; J. H. Szurszewski was responsible for critical revision of the manuscript for important intellectual content; S. J. Gibbons was responsible for the study concept and design, analysis and interpretation of data, drafting of the manuscript, critical revision of the manuscript for important intellectual content, statistical analysis, administrative, technical, or material support, and study supervision; and G. Farrugia was responsible for the study concept and design, analysis and interpretation of data, drafting of the manuscript, critical revision of the manuscript for important intellectual content, statistical analysis, obtained funding, administrative, technical, or material support, and study supervision.
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Supplementary Materials and Methods

Animals
These studies were approved by the Mayo Clinic Institutional Animal Care and Use Committee. Mice were humanely killed by carbon dioxide exposure followed by cervical dislocation. Mice homozygous for the Csf1 op mutation and WT littermates were studied. These mice were bred inhouse from a Csf1 op/þ colony of hemizygous breeders with founders originating from The Jackson Laboratory (Bar Harbor, ME). Wild-type Csf1 þ/þ mice were identified by genotyping as previously described.
1 Csf1 op/op mice were maintained on a specialized wet diet (Bio-serv, Frenchtown, NJ) after weaning at 3-4 weeks of age to keep their weight comparable with agematched WT mice (Supplementary Figure 1A) . After 12 weeks of age, Csf1 op/op mice were treated with CSF1 (2.5 mg intraperitoneally once daily, recombinant mouse macrophage colony stimulating factor-1 (rmM-CSF); Peprotech, Rocky Hill, NJ) (Figure 2A ).
Immunolabeling
The mucosa was removed and muscularis propria was fixed with 4% paraformaldehyde in 0.1 mol/L phosphate buffer for 4 hours. Then, whole mounts were rinsed in 0.1 mol/L phosphatebuffered saline and blocked in the presence of 10% normal donkey serum in phosphate-buffered saline and 0.3% Triton X-100 (Thermo Fisher, Waltham, MA) overnight at 4 C and gastric muscularis propria was labeled with primary antibodies overnight at 4 C. After washing, the tissue was incubated with secondary antibodies (Jackson ImmunoResearch, West Grove, PA), washed, and then incubated with 4',6-diamidino-2-phenylindole dilactate (Invitrogen, Carlsbad, CA) for 30 minutes. Neurons were identified by HuC/D-immunoreactivity (ANNA1, a gift from Dr Vanda Lennon, Mayo Clinic, Rochester, MN), cholinergic neurons using a goat anti-ChAT antibody (EMD Millipore, Burlington, MA), and nitrergic neurons using a rabbit anti-NOS1 antibody (EMD Millipore). Muscularis macrophages were identified using the MHCII primary antibody (eBioscience, Waltham, MA).
Controls omitting the primary antibody and controls in doublelabeling experiments that used the wrong secondary antibody were performed for all experiments. For quantification, 3 different fields were taken from the corpus and 3 from the antrum. The list of antibodies is shown in Supplementary Table 1.
Confocal Microscopy
A laser scanning confocal microscope using a 20Â, numerical aperture, (NA), 0.95 XLUMPlanFl objective (Olympus, Tokyo, Japan) in Fluoview (Olympus), with the optimal confocal aperture to provide a resolution of 0.994 Â 0.994 Â 1.13 mm (X Â Y Â Z), was used. Stacks of confocal images of the entire muscularis propria were collected from 4 different mice (n ¼ 4). For quantification of the labeling, all of the confocal image stacks were flattened into projections using the FV10-ASW Viewer (Olympus). The flattened images were renumbered in random order and the enteric neuronal number was determined while blinded to the source. All cells were counted from fields with dimensions of 636 Â 636 mm.
Images used for reconstruction and orthogonal view were taken from a Zeiss LSM 780 microscope using either a 40Â 1.2 NA water immersion objective at a resolution of 0.415 Â 0.415 Â 0.444, or a 100 Â 1.4 NA oil immersion objective at a resolution of 0.133 Â 0.133 Â 0.373 mm per pixel. Images were analyzed using ImarisMicroscopy Image Software by Bitplane (Supplementary Figure 1A) .
Isolation and Analysis of Gastric Muscularis Macrophages
Cell sorting was performed using a fluorescence activated cell sorting Aria Cell Sorter cytometer running fluorescence activated cell sorting Diva 6 software (Becton Dickinson, San Jose, CA), located in the Mayo Clinic Flow Cytometry Core Facility. Aliquots of cells were either unstained or stained with individual fluorescently labeled antibodies (Zurich, Switzerland, Supplementary Table 2) to establish instrument voltages, compensation, and appropriate gates. Each positive control tube was initially run without storing the data to ensure that the positive signals were on scale. Data were analyzed using FlowJo X software (Tree Star, Inc, Ashland, OR).
Gastric CD45 þ CD11b þ F4/80 þ cells were isolated directly into the lysing buffer provided by the RNeasy micro plus kit (Qiagen, Hilden, Germany). The extraction was performed following the instructions provided and the RNA concentration was determined by using a NanoDrop spectrophotometer. The RNA extracted was used for a real-time quantitative reverse-transcription polymerase chain reaction. The SuperScript VILO complementary DNA Synthesis Kit (Invitrogen) was used to generate complementary DNA. Quantitative reversetranscription polymerase chain reaction was performed on complementary DNA using commercial primer sets (Supplementary Table 3 ) and RT2SYBR Green/ROX quantitative reversetranscription polymerase chain reaction master mix according to the manufacturer's instructions (SABiosciences, Frederick, MD). The data were normalized to the expression of the glyceraldehyde-3-phosphate dehydrogenase by transforming the difference in threshold cycle for the gene of interest and the housekeeping gene to the second power, and expressed as the means ± SEM.
Statistics
Data are expressed as scatter plots with medians and quartiles and analyzed by the Mann-Whitney test. A P value less than .05 was considered significant. The method used for statistical analysis of 3 different groups was 1-way analysis of variance with multiple comparisons.
